Peripheral CB1 Cannabinoid Receptor Blockade Improves Cardiometabolic Risk in Mouse Models of Obesity
Journal of Clinical Investigation - United States
doi 10.1172/jci42551c1
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2010
Authors
Publisher
American Society for Clinical Investigation